ARTG Entry
PROQUAD
ARTG entry for PROQUAD (live varicella vaccine, Measles virus, Mumps virus, Rubella virus), ARTG 126153 — Product Information, dosage form, registration…
- Sponsor: Merck Sharp & Dohme
- Active ingredient: live varicella vaccine, Measles virus, Mumps virus, Rubella virus
- Therapeutic area: Infectious Disease
What it is
PROQUAD is a measles, mumps, rubella, varicella live virus vaccine.
Regulatory history
PROQUAD was first registered on the Australian Register of Therapeutic Goods on 8 February 2007. Three presentations are currently registered: a vial with prefilled diluent syringe (ARTG 126157), a vial (ARTG 126153), and a vial with sterile diluent vial composite pack (ARTG 337388), with the composite pack formulation registered on 12 August 2020.